The global MRI contrast media market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). MRI contrast media or agents are also known as gadolinium contrast media. These agents are chemical substances that are used in magnetic resonance imaging (MRI) scans. These agents are injected into the body to enhance and improve the quality of the MRI images. The major factor for the growth of the market is the new product launches and FDA approvals across the globe.
For instance, in December 2020, Bracco Diagnostics Inc. announced the approval of ProHance (Gadoteridol) Injection, 279.3 mg/mL by the US Food and Drug Administration (FDA) for intravenous use with magnetic resonance imaging (MRI) in pediatric patients under two years old. Additionally, in July 2019, Bayer AG announced that it has received US FDA approval for Gadavist injection to be used in cardiac magnetic resonance imaging (MRI) to assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD). Hence, the new FDA approvals are driving the growth of the global MRI contrast media market during the forecast period.
To Request a Sample of our Report on MRI Contrast Media Market: https://www.omrglobal.com/request-sample/mri-contrast-media-market
Some major players in the market include GE Healthcare, Bracco Imaging SPA, Bayer AG, Guerbet Group, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2019, Guerbet announced that it has signed a strategic partnership with InterSystems. This partnership was aimed to optimize the integration of the Contrast&Care, contrast media injection management solution into the IT systems of hospitals and medical imaging centres.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
· By Type
· By End-User
• Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
• Competitive Landscape- General Elecrric Co., Bracco Imaging S.p.A., and Bayer AG, among others.
(Get 15% Discount on Buying this Report)
A full Report of MRI Contrast Media Market is Available @ https://www.omrglobal.com/industry-reports/mri-contrast-media-market
Global MRI Contrast Media Market Report by Segment
By Type
• Iodinated Contrast Media
• Gadolinium-Based Contrast Media
• Microbubble Contrast Media
• Barium-Based Contrast Media
By End-User
• Hospitals
• Clinics
• Others
Global MRI Contrast Media Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
